TREVI THERAPEUTICS INC (TRVI) Stock Cash Flow
NASDAQ:TRVI - US89532M1018 - Common Stock
7.255 USD
+0.04 (+0.62%)
7.25 USD
0 (-0.07%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -47.30M | -47.91M | -29.07M | -29.15M | -33.94M | |||
| Depreciation Amortization | 152.00K | 147.00K | 123.00K | 40.00K | 50.00K | |||
| Change In Working Capital | 1.11M | 6.83M | -3.85M | -1.23M | 1.51M | |||
| Interest Paid | N/A | 4.00K | 331.00K | 590.00K | 600.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 3.35M | 2.68M | 1.08M | 2.17M | 3.44M | |||
| OPERATING CASH FLOW | -42.83M | -38.26M | -31.71M | -28.18M | -28.95M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -35.00K | -137.00K | -160.00K | 0.00 | |||
| Other Investing Activity | -28.75M | -21.49M | 59.56M | -107.21M | N/A | |||
| INVESTING CASH FLOW | -28.77M | -21.53M | 59.43M | -107.37M | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -77.00K | -126.00K | -9.50M | -5.83M | 0.00 | |||
| Stock Issued/Repurchased | 119.82M | 394.00K | 74.00K | 117.33M | 13.68M | |||
| Other Financing Activity | 55.80M | 61.22M | 1.52M | -190.00K | 7.09M | |||
| FINANCING CASH FLOW | 175.54M | 61.48M | -7.91M | 111.31M | 20.78M | |||
| CHANGE IN CASH | 103.94M | 1.70M | 19.81M | -24.24M | -8.17M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -42.83M | -38.26M | -31.71M | -28.18M | -28.95M | |||
| Capital Expenditure | N/A | -35.00K | -137.00K | -160.00K | 0.00 | |||
| FREE CASH FLOW | -42.84M | -38.29M | -31.85M | -28.34M | -28.95M | |||
All data in USD